LGM
TRML

Logos Global Management’s Tourmaline Bio TRML Stock Holding History

Logos Global Management’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-99,208
Closed -$2.27M – 73
2024
Q1 		$2.27M Sell
99,208
-185,164
-65% -$6.53M 0.18% 52
2023
Q4 		$7.44M Buy
+284,372
New +$5.69M 0.69% 33
2022
Q4 		– Sell
-19,791
Closed -$521K – 49
2022
Q3 		$521K Sell
19,791
-7,308
-27% -$266K 0.06% 37
2022
Q2 		$1.22M Sell
27,099
-3,525
-12% -$278K 0.22% 24
2022
Q1 		$3.01M Sell
30,624
-2,277
-7% -$213K 0.39% 29
2021
Q4 		$5.03M Sell
32,901
-17,891
-35% -$2.65M 0.52% 43
2021
Q3 		$6.89M Hold
50,792
– – 0.5% 38
2021
Q2 		$7.46M Buy
+50,792
New +$7.78M 0.63% 39

Other funds holding TRML

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

Logos Global Management's TRML Position: Q2 2024 in Review

Logos Global Management sold out of Tourmaline Bio (TRML) in Q2 2024, closing a stake of 99,208 shares — an estimated $2.27M sold.

Logos Global Management first reported a position in TRML in Q2 2021 and held it in 8 quarters. The position peaked at $7.46M in Q2 2021. 84 funds tracked by Wall St. Rank hold TRML as of Q2 2024.

  • Logos Global Management reported no remaining Tourmaline Bio position as of Q2 2024 after selling out during the quarter.
  • Logos Global Management sold 99,208 Tourmaline Bio shares in Q2 2024, an estimated $2.27M.
  • Logos Global Management first reported a position in Tourmaline Bio in Q2 2021 and held it in 8 quarters.
  • Logos Global Management's Tourmaline Bio position peaked at $7.46M in Q2 2021.
  • 84 funds tracked by Wall St. Rank held Tourmaline Bio as of Q2 2024.

Based on Logos Global Management's 13F filing for Q2 2024, filed 14 Aug 2024.